{"id":3697,"date":"2026-09-22T08:44:10","date_gmt":"2026-09-22T08:44:10","guid":{"rendered":"https:\/\/celiksoylaw.com\/tr\/approvals\/eb-2-niw-internal-medicine-specialist\/"},"modified":"2026-10-07T14:32:30","modified_gmt":"2026-10-07T14:32:30","slug":"ic-hastaliklari-uzmani-icin-eb-2-niw-onayi","status":"publish","type":"approval","link":"https:\/\/celiksoylaw.com\/tr\/onaylar\/ic-hastaliklari-uzmani-icin-eb-2-niw-onayi\/","title":{"rendered":"\u0130\u00e7 Hastal\u0131klar\u0131 Uzman\u0131na EB-2 NIW Onay\u0131"},"content":{"rendered":"<p>Yeti\u015fkin hasta bak\u0131m\u0131 ve klinik ara\u015ft\u0131rma \u00e7al\u0131\u015fmalar\u0131n\u0131 ABD&#8217;de s\u00fcrd\u00fcrmeyi planlayan bir i\u00e7 hastal\u0131klar\u0131 uzman\u0131n\u0131n EB-2 NIW I-140 ba\u015fvurusu i\u00e7in onay ald\u0131k. M\u00fcvekkilimizin deneyimi kronik hastal\u0131klar\u0131n y\u00f6netimini, koruyucu hekimli\u011fi ve birden fazla organ sistemini etkileyen durumlar\u0131n de\u011ferlendirilmesini kaps\u0131yordu.<\/p>\n<p>Ba\u015fvuruda klinik birikimini bilimsel \u00e7al\u0131\u015fmalar\u0131 ve gelecek plan\u0131yla birlikte sunduk. Pulmoner emboli risk de\u011ferlendirmesi \u00fczerine uzmanl\u0131k tezi ve akut b\u00f6brek hasar\u0131yla ilgili yay\u0131n\u0131, hasta bak\u0131m\u0131nda kar\u015f\u0131la\u015ft\u0131\u011f\u0131 sorular\u0131 ara\u015ft\u0131rmaya nas\u0131l ta\u015f\u0131d\u0131\u011f\u0131n\u0131 g\u00f6steren \u00f6rneklerdi.<\/p>\n<h2>Birden fazla hastal\u0131\u011f\u0131 olan yeti\u015fkinlerin bak\u0131m deneyimi<\/h2>\n<p>M\u00fcvekkilimiz t\u0131p e\u011fitimi ve i\u00e7 hastal\u0131klar\u0131 uzmanl\u0131\u011f\u0131n\u0131n ard\u0131ndan farkl\u0131 hastane ortamlar\u0131nda \u00e7al\u0131\u015fm\u0131\u015ft\u0131. Hasta de\u011ferlendirmesi, tan\u0131sal verilerin yorumlanmas\u0131, tedavi planlar\u0131n\u0131n olu\u015fturulmas\u0131 ve di\u011fer sa\u011fl\u0131k profesyonelleriyle bak\u0131m\u0131n koordinasyonu g\u00f6revleri aras\u0131ndayd\u0131.<\/p>\n<p>Diyabet, hipertansiyon ve tiroid hastal\u0131klar\u0131n\u0131n yan\u0131nda birden fazla sa\u011fl\u0131k sorunu bulunan hastalarla da \u00e7al\u0131\u015fm\u0131\u015ft\u0131. Koruyucu sa\u011fl\u0131k hizmetleri ve hastalar\u0131n kendi sa\u011fl\u0131klar\u0131 hakk\u0131nda bilgilendirilmesi, bu deneyimin di\u011fer par\u00e7alar\u0131yd\u0131.<\/p>\n<p>\u00c7al\u0131\u015fma kay\u0131tlar\u0131 ve uzman de\u011ferlendirmeleriyle g\u00f6revlerinin kapsam\u0131n\u0131 a\u00e7\u0131klad\u0131k. Hastan\u0131n genel sa\u011fl\u0131k durumunu, hastal\u0131klar aras\u0131ndaki etkile\u015fimi ve d\u00fczenli takip ihtiyac\u0131n\u0131 birlikte ele alan yakla\u015f\u0131m\u0131n\u0131 dosyada g\u00f6r\u00fcn\u00fcr k\u0131ld\u0131k.<\/p>\n<h2>Pulmoner emboli de\u011ferlendirmesine odaklanan uzmanl\u0131k tezi<\/h2>\n<p>Uzmanl\u0131k tezi, akci\u011fer damarlar\u0131nda p\u0131ht\u0131yla ili\u015fkili pulmoner embolinin de\u011ferlendirilmesinde kullan\u0131lan Wells ve Modifiye Geneva skorlar\u0131 aras\u0131ndaki ili\u015fkiyi inceliyordu. Ara\u015ft\u0131rma, i\u00e7 hastal\u0131klar\u0131 klini\u011findeki hasta grubuna odaklanm\u0131\u015ft\u0131.<\/p>\n<p>Bu \u00e7al\u0131\u015fma, klinik bir soruyu belirli bir y\u00f6ntemle inceleme deneyimini g\u00f6steriyordu. Belirtiler, klinik bulgular ve risk bilgilerinin yerle\u015fik skorlarla de\u011ferlendirilmesi ara\u015ft\u0131rman\u0131n konusuydu.<\/p>\n<p>Dosyada tezin amac\u0131n\u0131 ve kapsam\u0131n\u0131 ara\u015ft\u0131rma haz\u0131rl\u0131\u011f\u0131n\u0131n bir par\u00e7as\u0131 olarak anlatt\u0131k. Klinik g\u00f6zlemi analizle ve bulgular\u0131n yaz\u0131l\u0131 sunumuyla ili\u015fkilendirmesi, hekimlik g\u00f6revlerini a\u00e7\u0131klayan belgelere ayr\u0131 bir boyut kazand\u0131rd\u0131.<\/p>\n<h2>Akut b\u00f6brek hasar\u0131n\u0131n nedenlerine y\u00f6nelik \u00e7al\u0131\u015fma<\/h2>\n<p>Yay\u0131nlar\u0131ndan biri, multipl miyelom ile akut b\u00f6brek hasar\u0131 aras\u0131ndaki ili\u015fkiyi ele al\u0131yordu. Ara\u015ft\u0131rmac\u0131lar klinikte tan\u0131 alan vakalar\u0131 inceleyerek b\u00f6brek i\u015flevindeki bozulman\u0131n alt\u0131nda yatan nedenlerin belirlenmesini tart\u0131\u015ft\u0131.<\/p>\n<p>Bu \u00f6rnek, dahiliyenin farkl\u0131 hastal\u0131klar\u0131 birlikte de\u011ferlendiren yap\u0131s\u0131n\u0131 yans\u0131t\u0131yordu. B\u00f6brekle ilgili bir bulgunun, v\u00fccudu daha geni\u015f \u00f6l\u00e7ekte etkileyen bir hastal\u0131kla ba\u011flant\u0131s\u0131 olabiliyordu. Ortak ara\u015ft\u0131rmaya kat\u0131l\u0131m\u0131, klinik vakalar\u0131 inceleme ve g\u00f6zlemlerini bilimsel yay\u0131nla payla\u015fma deneyimini g\u00f6sterdi.<\/p>\n<p>Tezi ve yay\u0131n\u0131 birlikte ele alarak ara\u015ft\u0131rma ilgisinin pratik tan\u0131 sorular\u0131yla ba\u011flant\u0131s\u0131n\u0131 a\u00e7\u0131klad\u0131k. Bu \u00e7al\u0131\u015fmalar, ABD&#8217;de dahiliye ve klinik ara\u015ft\u0131rma alan\u0131nda devam etme plan\u0131n\u0131 destekleyen \u00f6rnekler olarak sunuldu.<\/p>\n<h2>Bilimsel de\u011ferlendirme ve mesleki geli\u015fim<\/h2>\n<p>M\u00fcvekkilimizin akademik faaliyetleri dergi hakemli\u011fini de kaps\u0131yordu. Destek yaz\u0131s\u0131nda t\u0131p ve eczac\u0131l\u0131k bilimleri dergileri i\u00e7in yapt\u0131\u011f\u0131 de\u011ferlendirmeler anlat\u0131l\u0131yordu. Bu belgeler, di\u011fer ara\u015ft\u0131rmac\u0131lar\u0131n \u00e7al\u0131\u015fmalar\u0131n\u0131 inceleme rol\u00fcn\u00fc g\u00f6sterdi.<\/p>\n<p>Kongre kay\u0131tlar\u0131 ve ortak bildirilere katk\u0131lar\u0131 da mesleki faaliyetlerine ili\u015fkin ba\u011flam sa\u011flad\u0131. Bunlar\u0131 meslek kurulu\u015fu \u00fcyelikleri ve uzman mektuplar\u0131yla birlikte de\u011ferlendirerek her belgenin hangi y\u00f6n\u00fcn\u00fc a\u00e7\u0131klad\u0131\u011f\u0131n\u0131 ortaya koyduk.<\/p>\n<p>Bu faaliyetler klinik deneyimini tamaml\u0131yor, t\u0131bbi bilginin payla\u015f\u0131lmas\u0131 ve de\u011ferlendirilmesine kat\u0131l\u0131m\u0131n\u0131 g\u00f6steriyordu.<\/p>\n<h2>ABD&#8217;de planlanan dahiliye ve ara\u015ft\u0131rma \u00e7al\u0131\u015fmalar\u0131<\/h2>\n<p>\u00c7al\u0131\u015fma plan\u0131, i\u00e7 hastal\u0131klar\u0131 alan\u0131nda devam etmeyi, di\u011fer profesyonellerle i\u015f birli\u011fi yapmay\u0131 ve hasta bak\u0131m\u0131 ile ara\u015ft\u0131rmaya katk\u0131 sunmay\u0131 kaps\u0131yordu. Kronik hastal\u0131k y\u00f6netimi, koruyucu hekimlik ve karma\u015f\u0131k sa\u011fl\u0131k ihtiya\u00e7lar\u0131 olan yeti\u015fkinlerin bak\u0131m\u0131n\u0131n koordinasyonu temel konulard\u0131.<\/p>\n<p>ABD a\u00e7\u0131s\u0131ndan \u00f6nemini gerek\u00e7elendirirken klinik deneyimle bilimsel faaliyetlerin birlikte halk sa\u011fl\u0131\u011f\u0131na sa\u011flayabilece\u011fi katk\u0131lar\u0131 ele ald\u0131k. \u00d6ng\u00f6r\u00fclen yararlar\u0131, e\u011fitimini, ilgili mesleki deneyimini ve ara\u015ft\u0131rma ge\u00e7mi\u015fini a\u00e7\u0131klayan belgelerle ili\u015fkilendirdik.<\/p>\n<p>Muafiyet gerek\u00e7esinde de uzmanl\u0131k birikimi ve ABD&#8217;de planlanan \u00e7al\u0131\u015fman\u0131n beklenen katk\u0131lar\u0131 \u00fczerinde durduk. Gelecek plan\u0131n\u0131, bu plan\u0131 ilerletmesini destekleyen deneyimle birlikte sunduk.<\/p>\n<h2>Ba\u015fvuruyu Destekleyen Kan\u0131tlar<\/h2>\n<p>Belge gruplar\u0131 niteliklerini, klinik deneyimini, ara\u015ft\u0131rma haz\u0131rl\u0131\u011f\u0131n\u0131 ve hedefledi\u011fi faaliyetleri farkl\u0131 y\u00f6nlerden a\u00e7\u0131klad\u0131.<\/p>\n<div class=\"cl-ap-tbl\">\n<table>\n<thead>\n<tr>\n<th>Kan\u0131t grubu<\/th>\n<th>Ba\u015fvurudaki rol\u00fc<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>T\u0131p ve uzmanl\u0131k belgeleri<\/td>\n<td>EB-2 uygunluk gerek\u00e7esini ve dahiliye alan\u0131ndaki e\u011fitim temelini destekledi.<\/td>\n<\/tr>\n<tr>\n<td>Hastane \u00e7al\u0131\u015fma kay\u0131tlar\u0131<\/td>\n<td>Farkl\u0131 ortamlarda kronik ve karma\u015f\u0131k hastal\u0131klarla ilgili g\u00f6revlerini a\u00e7\u0131klad\u0131.<\/td>\n<\/tr>\n<tr>\n<td>Uzmanl\u0131k tezi<\/td>\n<td>Pulmoner emboli risk de\u011ferlendirmesine ili\u015fkin y\u00f6ntemli ara\u015ft\u0131rma deneyimini g\u00f6sterdi.<\/td>\n<\/tr>\n<tr>\n<td>Akademik yay\u0131nlar<\/td>\n<td>Akut b\u00f6brek hasar\u0131 gibi klinik konular\u0131 inceleme ve bulgular\u0131 payla\u015fma \u00f6rnekleri sundu.<\/td>\n<\/tr>\n<tr>\n<td>Dergi hakemli\u011fi belgeleri<\/td>\n<td>Bilimsel \u00e7al\u0131\u015fmalar\u0131n de\u011ferlendirilmesine kat\u0131l\u0131m\u0131n\u0131 belgeledi.<\/td>\n<\/tr>\n<tr>\n<td>Kongre kay\u0131tlar\u0131 ve ortak bildirilere katk\u0131lar<\/td>\n<td>Mesleki geli\u015fim ve t\u0131bbi \u00e7al\u0131\u015fmalar\u0131n payla\u015f\u0131lmas\u0131na ili\u015fkin ba\u011flam sa\u011flad\u0131.<\/td>\n<\/tr>\n<tr>\n<td>Meslek kurulu\u015fu \u00fcyelikleri<\/td>\n<td>Alan\u0131yla ilgili kurulu\u015flardaki mesleki faaliyetlerini a\u00e7\u0131klad\u0131.<\/td>\n<\/tr>\n<tr>\n<td>Uzman mektuplar\u0131<\/td>\n<td>Klinik becerileri, ara\u015ft\u0131rma faaliyeti ve gelecek \u00e7al\u0131\u015fmalar\u0131na haz\u0131rl\u0131\u011f\u0131 hakk\u0131nda g\u00f6r\u00fc\u015fler sundu.<\/td>\n<\/tr>\n<tr>\n<td>ABD \u00e7al\u0131\u015fma plan\u0131<\/td>\n<td>Planlanan faaliyetleri tan\u0131mlay\u0131p mevcut birikimiyle ili\u015fkilendirdi.<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n<p>Bu kan\u0131tlar\u0131 klinik uygulama, ara\u015ft\u0131rma ve ABD&#8217;de hedeflenen katk\u0131 aras\u0131ndaki ili\u015fkiyi g\u00f6sterecek \u015fekilde d\u00fczenledik. G\u00f6rev kay\u0131tlar\u0131n\u0131 ve bilimsel faaliyetlerini \u00e7al\u0131\u015fma plan\u0131yla birlikte anlatmak, mesleki ge\u00e7mi\u015finin dosyadaki \u00f6nemini somutla\u015ft\u0131rd\u0131.<\/p>\n<p>Siz de i\u00e7 hastal\u0131klar\u0131 uzman\u0131 olarak EB-2 NIW ba\u015fvurusunu d\u00fc\u015f\u00fcn\u00fcyorsan\u0131z, planlad\u0131\u011f\u0131n\u0131z \u00e7al\u0131\u015fmay\u0131 ve bunu destekleyen belgeleri birlikte de\u011ferlendirebiliriz. Klinik deneyiminiz, ara\u015ft\u0131rmalar\u0131n\u0131z ve ABD&#8217;deki hedefleriniz hakk\u0131nda g\u00f6r\u00fc\u015fmek i\u00e7in <a href=\"mailto:us@celiksoylaw.com\">us@celiksoylaw.com<\/a> adresinden bize ula\u015fabilirsiniz.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Kronik hastal\u0131k y\u00f6netimi ve yeti\u015fkin hasta bak\u0131m\u0131 deneyimini klinik ara\u015ft\u0131rmalarla birle\u015ftiren bir dahiliye uzman\u0131n\u0131n ABD&#8217;de \u00e7al\u0131\u015fma plan\u0131 i\u00e7in NIW I-140 onay\u0131 ald\u0131k.<\/p>\n","protected":false},"featured_media":4611,"menu_order":30,"template":"","meta":{"cl_author_id":0,"ap_case_type":"EB-2 NIW","ap_applicant":"\u0130\u00e7 Hastal\u0131klar\u0131 Uzman\u0131 ve Ara\u015ft\u0131rmac\u0131 Hekim","ap_focus_label":"Uzmanl\u0131k Alan\u0131","ap_focus":"\u0130\u00e7 Hastal\u0131klar\u0131, Kronik Hastal\u0131k Y\u00f6netimi ve Koruyucu Hekimlik","ap_approval_type":"I-140 G\u00f6\u00e7men Dilek\u00e7esi Onay\u0131","ap_notice":0,"ap_profile":"[[\"Ba\u015fvuru T\u00fcr\u00fc\",\"EB-2 NIW\"],[\"Ba\u015fvuru Sahibi\",\"\u0130\u00e7 Hastal\u0131klar\u0131 Uzman\u0131 ve Ara\u015ft\u0131rmac\u0131 Hekim\"],[\"Uzmanl\u0131k Alan\u0131\",\"Yeti\u015fkin Hasta Bak\u0131m\u0131, Kronik Hastal\u0131k Y\u00f6netimi ve Koruyucu Hekimlik\"],[\"Ara\u015ft\u0131rma Konular\u0131\",\"Pulmoner Emboli Risk De\u011ferlendirmesi ve Akut B\u00f6brek Hasar\u0131\"],[\"Onay T\u00fcr\u00fc\",\"I-140 G\u00f6\u00e7menlik Ba\u015fvurusu Onay\u0131\"]]","ap_card_title":"\u0130\u00e7 Hastal\u0131klar\u0131 Uzman\u0131na EB-2 NIW Onay\u0131","ap_hide_notice":"","footnotes":""},"approval_type":[34],"approval_region":[37],"class_list":["post-3697","approval","type-approval","status-publish","has-post-thumbnail","hentry","approval_type-eb-2-niw","approval_region-us"],"_links":{"self":[{"href":"https:\/\/celiksoylaw.com\/tr\/wp-json\/wp\/v2\/approval\/3697","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/celiksoylaw.com\/tr\/wp-json\/wp\/v2\/approval"}],"about":[{"href":"https:\/\/celiksoylaw.com\/tr\/wp-json\/wp\/v2\/types\/approval"}],"version-history":[{"count":5,"href":"https:\/\/celiksoylaw.com\/tr\/wp-json\/wp\/v2\/approval\/3697\/revisions"}],"predecessor-version":[{"id":5425,"href":"https:\/\/celiksoylaw.com\/tr\/wp-json\/wp\/v2\/approval\/3697\/revisions\/5425"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/celiksoylaw.com\/tr\/wp-json\/wp\/v2\/media\/4611"}],"wp:attachment":[{"href":"https:\/\/celiksoylaw.com\/tr\/wp-json\/wp\/v2\/media?parent=3697"}],"wp:term":[{"taxonomy":"approval_type","embeddable":true,"href":"https:\/\/celiksoylaw.com\/tr\/wp-json\/wp\/v2\/approval_type?post=3697"},{"taxonomy":"approval_region","embeddable":true,"href":"https:\/\/celiksoylaw.com\/tr\/wp-json\/wp\/v2\/approval_region?post=3697"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}